Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MdmX inhibits Smad transactivation.

Madhavi Kadakia1, Thomas L Brown, Molly M McGorry

  • 1Department of Biochemistry and Molecular Biology, Wright State University, Dayton, Ohio, USA.

Oncogene
|December 17, 2002
PubMed
Summary

MdmX protein inhibits Smad-induced transactivation, a key part of TGF-beta signaling, by interacting with the coactivator p300. This finding offers new insights into cancer growth regulation pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic Extracellular Vesicles in Severe Early-Onset Preeclampsia Inhibit Angiogenesis in a Dose-Dependent Manner.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Severe early-onset preeclampsia is significantly associated with metabolic dysregulation and sustained elevation of placental HIF-1α.

Placenta·2026
Same author

p63 and p73 regulate convergent and factor-specific transcriptional programs in cutaneous squamous cell carcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Concordant and Discordant Transcriptomic Signatures of Twin Placentas in the Setting of Preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Trophoblast-specific overexpression of Slc7a5 increases fetal amino acid availability and hepatic mTOR signalling and causes increased fetal growth.

The Journal of physiology·2026
Same author

Important Aspects of siRNA Design for Optimal Efficacy In Vitro and In Vivo.

International journal of cell biology·2026

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Mdm2 overexpression promotes cell growth by downregulating p53.
  • Mdm2 deregulation can inhibit TGF-beta growth repression independently of p53.
  • Smads are key downstream signaling elements of the TGF-beta pathway.

Purpose of the Study:

  • To investigate if Mdm2 or MdmX overexpression affects Smad-induced transactivation.
  • To determine the mechanism by which MdmX influences Smad activity.

Main Methods:

  • Deletion mutant analysis of MdmX.
  • Overexpression studies in TGF-beta sensitive HepG2 cells.
  • Analysis of Smad transactivation in mouse embryo fibroblasts (MEFs) lacking p53 and/or MdmX.
  • In vitro binding assays.

Main Results:

  • MdmX, but not Mdm2, inhibits Smad-induced transactivation.
  • MdmX inhibition requires amino acid residues 128-444 and is independent of p53 and Mdm2 interaction domains.
  • MdmX overexpression inhibits TGF-beta induced Smad transactivation in HepG2 cells.
  • MEFs lacking p53 and MdmX show enhanced Smad transactivation compared to other knockout lines.
  • p300 reverses MdmX-mediated inhibition of Smad transactivation.
  • MdmX binds to p300, Smad3, and Smad4.

Conclusions:

  • MdmX inhibits Smad-induced transactivation through a mechanism involving its interaction with the coactivator p300.
  • This interaction likely alters the ability of Smads to interact with p300, impacting TGF-beta signaling.
  • The findings suggest a novel role for MdmX in regulating TGF-beta pathway activity, independent of its interaction with p53.

Related Experiment Videos